SK-MEL-28 (Q54954013)

31 January 2023

1 reference

AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization

31 January 2023

1 reference

31 January 2023

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

1 reference

31 January 2023

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

31 January 2023

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

31 January 2023

Induction of growth factor RNA expression in human malignant melanoma: markers of transformation

1 reference

31 January 2023

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

31 January 2023

Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression

1 reference

31 January 2023

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

31 January 2023

Human tumor lines for cancer research.

1 reference

31 January 2023

A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.

1 reference

31 January 2023

Two Distinct Cytotoxic T Lymphocyte Subpopulations in Patients with Vogt-Koyanagi-Harada Disease that Recognize Human Melanoma Cells

1 reference

31 January 2023

Detection of melanoma cells in bone marrow using monoclonal antibodies( a comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF))

1 reference

31 January 2023

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies

1 reference

31 January 2023

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

31 January 2023

Serological survey of normal humans for natural antibody to cell surface antigens of melanoma

1 reference

31 January 2023

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

31 January 2023

Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays

1 reference

31 January 2023

CDKN2A/p16 is inactivated in most melanoma cell lines

1 reference

31 January 2023

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

31 January 2023

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

1 reference

31 January 2023

Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.

1 reference

31 January 2023

Mutations of the BRAF gene in human cancer

1 reference

31 January 2023

Regulation of intracellular pH in human melanoma: potential therapeutic implications.

1 reference

31 January 2023

Characterization of human melanoma cell lines according to their migratory properties in vitro

1 reference

31 January 2023

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

1 reference

31 January 2023

p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas

1 reference

31 January 2023

Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.

1 reference

31 January 2023

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

31 January 2023

Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

1 reference

31 January 2023

Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma

1 reference

31 January 2023

Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.

1 reference

31 January 2023

Confirmation of a BRAF mutation-associated gene expression signature in melanoma.

1 reference

31 January 2023

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

1 reference

31 January 2023

Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas

1 reference

31 January 2023

Genomic and molecular profiling predicts response to temozolomide in melanoma

1 reference

31 January 2023

DNA fingerprinting of the NCI-60 cell line panel

1 reference

31 January 2023

A gene expression signature of invasive potential in metastatic melanoma cells

1 reference

31 January 2023

Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.

1 reference

31 January 2023

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

31 January 2023

Identification of cancer cell-line origins using fluorescence image-based phenomic screening

1 reference

31 January 2023

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

31 January 2023

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

31 January 2023

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

1 reference

31 January 2023

Global proteome analysis of the NCI-60 cell line panel

1 reference

31 January 2023

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

1 reference

31 January 2023

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

31 January 2023

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner

1 reference

31 January 2023

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

31 January 2023

Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line

1 reference

31 January 2023

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR

1 reference

31 January 2023

A landscape of pharmacogenomic interactions in cancer.

1 reference

31 January 2023

A map of mobile DNA insertions in the NCI-60 human cancer cell panel.

1 reference

31 January 2023

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

31 January 2023

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

31 January 2023

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines

1 reference

31 January 2023

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.

1 reference

31 January 2023

Identification of novel and widely expressed cancer/testis gene isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to melanoma

1 reference

31 January 2023

HLA class I and II genotype of the NCI-60 cell lines

1 reference

31 January 2023

Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy

1 reference

31 January 2023

Signatures of mutation and selection in the cancer genome

1 reference

31 January 2023

Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.

1 reference

31 January 2023

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

1 reference

31 January 2023

Functional profiling of live melanoma samples using a novel automated platform

1 reference

31 January 2023

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines

1 reference

31 January 2023

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

1 reference

31 January 2023

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas

1 reference

31 January 2023

Genetic alterations in main candidate genes during melanoma progression.

1 reference

31 January 2023

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

31 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

31 January 2023

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

31 January 2023

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer

1 reference

31 January 2023

Thymine DNA glycosylase as a novel target for melanoma

1 reference

31 January 2023

Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.

1 reference

31 January 2023

established from medical condition

skin melanoma

1 reference

31 January 2023

derived from organism type

1 reference

http://purl.obolibrary.org/obo/BTO_0002131

31 January 2023

1 reference

31 January 2023

http://purl.obolibrary.org/obo/EFO_0003081

1 reference

31 January 2023

http://purl.obolibrary.org/obo/CLO_0009043

1 reference

31 January 2023

Identifiers

Cell Line Ontology ID

CLO_0009043

1 reference

31 January 2023

1 reference

31 January 2023